Effects of ionotropic glutamate receptor channel blockers on the development of pentylenetetrazol kindling in mice

Neuroscience and Behavioral Physiology

Volumn 37, Issue 1, 2007, Pages 75-81

  Lukomskaya, N Ya ^a   Lavrent'eva, V V ^a   Starshinova, L A ^a   Zhabko, E P ^a   Gorbunova, L V ^a   Tikhonova, T B ^a   Gmiro, V E ^b   Magazanik, L G ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

AMPA receptors; Channel blockers; Kindling; Mice; NMDA receptors; Pentylenetetrazol

Indexed keywords

1 ADAMANTYLMETHYLAMMONIO 5 AMMONIOPENTANE DIBROMIDE; ADAMANTANE DERIVATIVE; AMPA RECEPTOR; BENZENE DERIVATIVE; CATION; IEM 1921; IEM 2046; IONOTROPIC RECEPTOR ANTAGONIST; MEMANTINE; N (5 AMMONIOPENTYL) 1 PHENYLCYCLOHEXYLAMMONIUM DIBROMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PENTETRAZOLE; PHENYLCYCLOHEXYL DERIVATIVE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG STRUCTURE; KINDLING; KINETICS; MOUSE; NONHUMAN; RECEPTOR DENSITY;

ANIMALS; BEHAVIOR, ANIMAL; CYCLOHEXYLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; GABA ANTAGONISTS; KINDLING, NEUROLOGIC; MEMANTINE; MICE; PENTYLENETETRAZOLE;

EID: 33845707539     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-007-0152-y     Document Type: Article

References (33)

1. N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, K. V. Bol'shakov, and L. G. Magazanik, "Comparison of the anti-convulsive activities of organic mono-and dications with their abilities to inhibit NMDA and AMPA glutamate receptors," Ros. Fiziol. Zh. im. I. M. Sechenova, 88, 1161-1171 (2002).
2. N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and L. G. Magazanik, "Studies of the roles of NMDA and AMPA glutamate receptors in the mechanism of Corasol convulsions in mice," Ros. Fiziol. Zh. im. I. M. Sechenova, 89, No. 3, 292-301 (2003).
3. L. G. Magazanik, K. V. Bol'shakov, S. L. Buldakova, V. E. Gmiro, N. A. Dorofeeva, N. Ya. Lukomskaya, N. N. Potap'eva, M. V. Samoilov, D. B. Tikhonov, I. M. Fedorova, and E. V. Frolova, "Structural characteristics of ionotropic glutamate receptors detected by channel blockade," Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 9, 1138-1151 (2000).
4. N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Ya. Lukomskaya, "The ability of a number of non-competitive glutamate receptor blockers to ameliorate motor disorders in animals," Ros. Fiziol. Zh. im. I. M. Sechenova, 87, No. 9, 1260-1267 (2001).
5. T. B. Tikhonova, D. B. Tikhonov, and L. G. Magazanik, "Characteristics of blockade of the ion channels of glutamate channels of the NMDA and AMPA subtypes by dicationic derivatives of phenylcyclohexyl," Biol. Membrany, 22, No. 4, 311-320 (2005).
6. A. Becker, G. Greksch, and H. Schroder, "Low doses of AMPA exert anticonvulsant effects on pentylenetetrazol-kindled seizures," Pharmacol. Biochem. Behav., 70, 421-426 (2001).
7. J. Bengzon, S. Okabe, O. Lindvall, and R. D. McKay, "Suppression of epileptogenesis by modification of N-methyl-D-aspartate receptor subunit composition," Eur. J. Neurosci., 11, 916-922 (1999).
8. K. V. Bolshakov, D. B. Tikhonov, V. E. Gmiro, and L. G. Magazanik, "Different arrangements of hydrophobic and nucleophilic components of channel binding sites in N-methyl-D-aspartate and AMPA receptors of rat brain is revealed by channel blockade," Neurosci. Lett., 291, 101-104 (2000).
9. K. V. Bolshakov, V. E. Gmiro, D. B. Tikhonov, and L. G. Magazanik, "Determinants of trapping block of N-methyl-D-aspartate receptor channels," J. Neurochem., 87, 56-65 (2003).
10. K. V. Bolshakov K. H. Kim, N. N. Potapjeva, V. E. Gmiro, D. B. Tikhonov, P. N. R. Usherwood, I. R. Mellor, and L. G. Magazanik, "Design of antagonists for NMDA and AMPA receptors," Neuropharmacology (in press) (2005).
11. M. G. Corda, M. Orlandi, D. Lecca, G. Carboni, V. Frau, and O. Giorgi, "Pentylenetetrazol-induced kindling in rats: Effect of GABA function inhibitors," Pharmacol. Biochem. Behav., 40, 329-333 (1991).
12. M. G. Corda, M. Orlandi, D. Lecca, and O. Giorgi, "Decrease in GABAergic function induced by pentylenetetrazol kindling in rats: antagonism by MK-801," J. Pharmacol. Exp. Ther., 262, 792-800 (1992).
13. D. A. Coulter, D. C. McIntyre, and W. Loscher, "Animal models of limbic epilepsies: What can they tell us?" Brain Pathol., 12, 240-256 (2002).
14. M. J. Croucher, K. L. Cottrell, and H. F. Bradford, "Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling," Eur. J. Pharmacol., 286, 265-271 (1995).
15. M. J. Croucher, K. L. Ruffle, and H. F. Bradford, "The effects of focal N-methyl-D-aspartate pretreatment on the parameters of amygdaloid electrical kindling," Eur. J. Pharmacol., 319, 207-213 (1997).
16. G. De Sarro, E. Palma, N. Costa, R. Marra, S. Gratteri, A. De Sarro, and D. Rotiroti, " Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice," Neuropharmacol., 39, 2147-2161 (2000).
17. N. Durmuller, M. Craggs, and B. S. Meldrum, "The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures," Epilepsy Res., 17, 167-174 (1994).
18. A. Ekonomou, A. L. Smith, and F. Angelatou, "Changes in AMPA receptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced 'kindling' model of epilepsy," Brain Res. Mol. Brain Res., 95, 27-35 (2001).
19. G. Getova, W. Froestl, and N. G. Bowery, "Effects of GABAB receptor antagonism on the development of pentylenetetrazol-induced kindling in mice," Brain Res., 809, 182-188 (1998).
20. H. Klitgaard, A. Matagne, and Y. Lamberty, "Use of epileptic animals for adverse effect testing," Epilepsy Res., 50, 55-65 (2002).
21. W. Loscher, "Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy," Prog. Neurobiol., 54, 721-741 (1998).
22. W. Loscher and D. Honack, "High doses of memantine (l-amino-3,5-dimethyladamantane) induce seizures in kindled but not in nonkindled rats," Naunyn Schmiedebergs Arch. Pharmacol., 341, 476-481 (1990).
23. W. Loscher, B. Nolting, and D. Honack, "Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital," Eur. J. Pharmacol., 152, 9-17 (1988).
24. W. Loscher, C. Rundfeldt, and D. Honack, "Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy," Eur. J. Neurosci., 5, 1545-1550 (1993).
25. L. G. Magazanik, S. L. Buldakova, M. V. Samoilova, V. E. Gmiro, I. R. Mellor, and P. N. Usherwood, " Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives," J. Physiol., 505, 655-663 (1997).
26. K. Morimoto, M. Fahnestock, and R. J. Racine, "Kindling and status epilepticus models of epilepsy: Rewiring the brain," Prog. Neurobiol., 73, 1-60 (2004).
27. T. Namba, K. Morimoto, K. Sato, N. Yamada, and S. Kuroda, "Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy," Brain Res., 638, 36-44 (1994).
28. C. G. Parsons, W. Danysz, and G. Quack, "Glutamate in CNS disorders as a target for drug development: An update," Drug. New Perspect., 11, 523-569 (1998).
29. M. A. Rogawski, P. S. Kurzman, S. I. Yamaguchi, and H. Li, "Role of AMPA and GluR5 kainate receptors in the development and expression of amygdala kindling in the mouse," Neuropharmacol., 40, 28-35 (2001).
30. M. V. Samoilova, S. L. Buldakova, V. S. Vorobjev, I. N. Sharonova, and L. G. Magazanik, "The open channel blocking drug, IEM-1460, reveals functionally distinct alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors in rat brain neurons," Neurosci., 94, 261-268 (1999).
31. M. Schmutz, C. Pertert, A. Jeker, K. Klebs, A. Vassout, H. Allgeier, R. Heckendorn, G. E. Fagg, H. R. Olpe, and H. Van Riezen, "The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents," Naunyn Schmiedebergs Arch. Pharmacol., 342, 61-66 (1990).
32. S. N. Skatchkov, S. L. Buldakova, R. W. Veh, A. Reichenbach, and M. J. Eaton, "AMPAR channel block and potentiation by spermine and IBM 1460," Author's Abstract of Thesis for Doctorate in Medical Sciences, Soc. Neurosci. (2002).
33. L. Velisek, H. Kubova, P. Mares, and D. Vachova, "Kainate/AMPA receptor antagonists are anticonvulsant against the tonic hindlimb component of pentylenetetrazol-induced seizures in developing rats," Pharmacol. Biochem. Behav., 51, No. 1, 153-158 (1995).